StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hualan Biological Bacterin Inc.
Shenzhen Stock Exchange:301207.SZ
Sector
Industries
Location
Market Cap
USD 1.46 B
Share Price
USD 2.39
Avg Daily Volume
1,959,987
Change (1 day)
1.20%
Change (1 year)
4.28%
Change (YTD)
-0.35%
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2024: USD 64.10 M
Hualan Biological Bacterin Inc. Operating Cash Flow is USD 64.10 M for the year ending December 31, 2024, a -48.75% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2023 was USD 125.08 M, a 199.02% change year over year.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2022 was USD 41.83 M, a -53.32% change year over year.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2021 was USD 89.60 M, a -15.69% change year over year.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2020 was USD 106.28 M, a 169.08% change year over year.
Competitors
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Moderna, Inc.
USD 34.28
MRNA
+1.49
4.54%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Swedish Orphan Biovitrum AB (publ)
USD 30.75
SOBI.ST
+1.06
3.56%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.87
300122.SZ
+0.09
3.15%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
-0.45
-1.05%
Rhythm Pharmaceuticals, Inc.
USD 89.04
RYTM
+0.04
0.04%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.93
1877.HK
-0.07
-2.30%
Vaxcyte, Inc.
USD 36.24
PCVX
+0.46
1.29%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
+0.01
0.57%
NewAmsterdam Pharma Company N.V.
USD 22.02
NAMS
+0.38
1.76%
Apellis Pharmaceuticals, Inc.
USD 19.53
APLS
+0.32
1.67%
Ligand Pharmaceuticals Incorporated
USD 124.98
LGND
+2.58
2.11%
Bavarian Nordic A/S
USD 28.76
BAVA.CO
+1.24
4.51%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
ARS Pharmaceuticals, Inc.
USD 17.98
SPRY
+0.08
0.45%
Immunocore Holdings plc
USD 35.45
IMCR
+0.87
2.52%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Moderna, Inc.
USD 34.28
MRNA
+1.49
4.54%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Swedish Orphan Biovitrum AB (publ)
USD 30.75
SOBI.ST
+1.06
3.56%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.87
300122.SZ
+0.09
3.15%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
-0.45
-1.05%
Rhythm Pharmaceuticals, Inc.
USD 89.04
RYTM
+0.04
0.04%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.93
1877.HK
-0.07
-2.30%
Vaxcyte, Inc.
USD 36.24
PCVX
+0.46
1.29%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
+0.01
0.57%
NewAmsterdam Pharma Company N.V.
USD 22.02
NAMS
+0.38
1.76%
Apellis Pharmaceuticals, Inc.
USD 19.53
APLS
+0.32
1.67%
Ligand Pharmaceuticals Incorporated
USD 124.98
LGND
+2.58
2.11%
Bavarian Nordic A/S
USD 28.76
BAVA.CO
+1.24
4.51%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
ARS Pharmaceuticals, Inc.
USD 17.98
SPRY
+0.08
0.45%
Immunocore Holdings plc
USD 35.45
IMCR
+0.87
2.52%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%